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a b s t r a c t 
The mevalonate pathway is normally found in eukaryotes, and allows for the production of isoprenoids, a 
useful class of organic compounds. This pathway has been successfully introduced to Escherichia coli , en- 
abling a biosynthetic production route for many isoprenoids. In this paper, we develop and solve a math- 
ematical model for the concentration of metabolites in the mevalonate pathway over time, accounting 
for the loss of acetyl-CoA to other metabolic pathways. Additionally, we successfully test our theoretical 
predictions experimentally by introducing part of the pathway into Cupriavidus necator . In our model, we 
exploit the natural separation of time scales as well as of metabolite concentrations to make signiﬁcant 
asymptotic progress in understanding the system. We conﬁrm that our asymptotic results agree well with 
numerical simulations, the former enabling us to predict the most important reactions to increase isopen- 
tenyl diphosphate production whilst minimizing the levels of HMG-CoA, which inhibits cell growth. Thus, 
our mathematical model allows us to recommend the upregulation of certain combinations of enzymes 
to improve production through the mevalonate pathway. 
© 2017 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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0. Introduction 
Isoprenoids are a diverse class of naturally occurring organic
hemicals found in all organisms. In plants, isoprenoids are the
ause of many aromas and, in animals, isoprenoids form steroids
nd sterols. The wide range of isoprenoid products is one rea-
on why the successful introduction of a viable isoprenoid path-
ay to Escherichia coli by Martin et al. (2003) (in this case to
roduce amorpha-4,11-diene, a pre-cursor to the antimalarial com-
ound artemisinin) was a major breakthrough in synthetic biology.
ince then, a signiﬁcant amount of experimental work has been
arried out to improve the yield from this pathway (see, for exam-
le, Anthony et al., 2009; Kizer et al., 2008; Newman et al., 2006;
itera et al., 2007; Tabata and Hashimoto, 2004 ). 
There are two main pathways from pyruvate to isopentenyl
iphosphate (IDP) and dimethylallyl diphosphate (DMADP), and
hese two products can react to make isoprenoid compounds. IDP
nd DMADP are essentially interchangeable due to the enzyme
sopentenyl diphosphate isomerase that allows conversion between
he two. The ﬁrst pathway is known as the mevalonate pathway,∗ Corresponding author. 
E-mail address: mohit.dalwadi@nottingham.ac.uk (M.P. Dalwadi). 
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ttps://doi.org/10.1016/j.jtbi.2017.11.022 
022-5193/© 2017 The Authors. Published by Elsevier Ltd. This is an open access article und starts from acetyl coenzyme A (acetyl-CoA), mainly derived
rom pyruvate, which is converted to IDP via the key pathway
ntermediate mevalonate. The second pathway is known as the
on-mevalonate or, alternatively, the 2-C-methyl- D -erythritol 4-
hosphate/1-deoxy- D -xylulose 5-phosphate (MEP/DOXP) pathway,
nd also converts pyruvate to IDP. The mevalonate pathway was
he ﬁrst to be discovered, and occurs naturally in eukaryotes. The
on-mevalonate pathway mainly occurs in bacteria (with some ex-
eptions), and some plants. 
The reason for introducing the mevalonate pathway to E. coli , a
acterium that naturally expresses only the non-mevalonate path-
ay, is to bypass the natural negative feedback mechanisms in
lace that would ordinarily prevent the overproduction of iso-
renoids. We are interested in mathematically modelling this
evalonate pathway, with the goal of understanding how to fur-
her modify the pathway by, for example, upregulating genes that
ontrol certain enzymes, in order to produce more IDP. The meval-
nate pathway we will model comprises the following: 
yruvate 
k 1 → Acetyl-CoA , (1a) 
cetyl-CoA 
k 2 
k −2 
Acetoacetyl-CoA , (1b) nder the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Fig. 1. A schematic network diagram for the pathway we consider in this paper, where arrows denote the direction of the reactions. We only track the metabolites included 
in this Figure and, speciﬁcally, not any involved in the acetyl-CoA sink. Where we write E i (for i = 1 , . . . , 7 ) next to a reaction arrow, this denotes a speciﬁc enzyme that 
controls the reaction. Hence, E 1 corresponds to the pyruvate dehydrogenase complex (EC 1.2.4.1, EC 2.3.1.12, and EC 1.8.1.4), E 2 corresponds to acetyl-CoA acetyltransferase 
(EC 2.3.1.9), E 3 corresponds to HMG-CoA synthase (EC 2.3.3.10), E 4 corresponds to HMG-CoA reductase (EC 1.1.1.34), E 5 corresponds to mevalonate kinase (EC 2.7.1.36), E 6 
corresponds to phosphomevalonate kinase (EC 2.7.4.2), and E 7 corresponds to mevalonate diphosphate decarboxylase (EC 4.1.1.33). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 
Dimensional and dimensionless variable deﬁnitions. 
Original variable Description Nondimensionalisation 
[ S 1 ] Pyruvate [ S 1 ] = S 0 S 1 
[ S 2 ] Acetyl CoA [ S 2 ] = S 0 S 2 
[ S 3 ] Acetoacetyl-CoA [ S 3 ] = S 0 S 3 
[ S 4 ] HMG-CoA [ S 4 ] = S 0 S 4 
[ S 5 ] Mevalonate [ S 5 ] = S 0 S 5 
[ S 6 ] Mevalonate phosphate [ S 6 ] = S 0 S 6 
[ S 7 ] Mevalonate diphosphate [ S 7 ] = S 0 S 7 
[ P ] Isopentenyl diphosphate [ P] = S 0 P
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d  Acetyl-CoA 
A → φ, (1c)
Acetoacetyl-CoA + Acetyl-CoA k 3 → HMG-CoA , (1d)
HMG-CoA 
k 4 → Mevalonate , (1e)
Mevalonate 
k 5 → Mevalonate phosphate , (1f)
Mevalonate phosphate 
k 6 → Mevalonate diphosphate , (1g)
Mevalonate diphosphate 
k 7 → Isopentenyl diphosphate , (1h)
where (1c) represents the loss of acetyl-CoA to other metabolic
pathways, such as the citric acid cycle or any pathways directly
involved with fatty acid biosynthesis. Moreover, we will not keep
track of any metabolites associated with this acetyl-CoA sink. We
show a schematic of the pathway in Fig. 1 . 
In general, the aim of our model is to determine which reac-
tions are the most important for IDP production without resort-
ing to expensive and time-consuming experiments. We are also in-
terested in determining which reactions have the most signiﬁcant
control over the levels of 3-hydroxy-3-methylglutaryl-coenzyme A
(HMG-CoA), linked to the inhibition of cell growth due to its in-
hibition of fatty acid biosynthesis ( Kizer et al., 2008 ). Speciﬁcally,
we will be interested in maintaining low levels of HMG-CoA whilst
increasing IDP production. 
We make several key modelling assumptions to facilitate anal-
ysis of our system. Firstly, we assume that the formation rate of
enzyme complex is much quicker than the rate of substrate con-
sumption, and thus the reaction rates are governed by Michaelis–
Menten-type laws, the speciﬁc form of which we obtain from the
literature. We also consider a system that is well mixed and thus
spatially independent. Additionally, we consider the case where
pyruvate is instantaneously introduced to a system containing all
of the relevant enzymes, but none of the intermediate metabolites,
allowing for a cleaner mathematical analysis. We ﬁrst investigate
the case where pyruvate is continuously replenished and held at
a constant concentration, then the case where pyruvate is never
replenished. We show that the second case shares many similari-
ties with the ﬁrst until the pyruvate is depleted to a certain criti-
cal level, which we determine. Understanding these extreme cases
allows us to determine the key reactions in this pathway, and to
suggest targets for upregulation. 
As is the case with many biological systems, there are many
parameters in the system. Thus, a comprehensive understanding of
the system using a purely experimental approach would be very
time consuming. This reasoning also applies to investigating ourathematical model using a fully numerical approach, although
he time taken to investigate the system would be shorter than the
urely experimental approach. To get around this issue, we supple-
ent and guide our numerical simulations by determining asymp-
otic approximations (see, for example, Hinch, 1991; Kevorkian and
ole, 2013; O’Malley, Jr., 2012 ) of the metabolite concentrations.
his will enhance our physical insight into the underlying system
nd allow us to determine how the concentrations vary as func-
ions of the experimental parameters. Moreover, this approach al-
ows us to bypass the issue we have with the uncertainty in the
arameters, as this method only requires an idea of the order of
agnitude of each parameter. 
Finally, to test our theoretical predictions, we introduce part
f the mevalonate pathway (from acetyl-CoA to mevalonate) into
upriavidus necator by transforming it with a plasmid harbour-
ng the mvaE and mvaS genes from Enterococcus faecalis under the
ontrol of the P BAD L -arabinose inducible promoter. The mvaE and
vaS genes code for the enzymes responsible for the conversion of
cetyl-CoA to mevalonate (in the ﬁrst half of the mevalonate path-
ay). We show that mevalonate can be produced by our bacterial
hassis, and conﬁrm that our experimental results are successfully
redicted by our model. 
The outline of this paper is as follows. We introduce a math-
matical model to describe the nonlinear reaction kinetics in
ection 2 . We solve this system in Section 3 , where we give both
umerical and asymptotic solutions to describe the system be-
aviour. In that section, we consider the continuous replenishment
f pyruvate case ﬁrst, then we consider the no replenishment of
yruvate case. We discuss the experimental procedure and results
n Section 4 , and compare these results to our model predictions.
e ﬁnish by discussing our results and comparing the two regimes
n Section 5 . 
. Model description 
The dimensional system we consider is derived from Michaelis–
enten-type laws found in the literature, where each variable is
eﬁned in Table 1 . The forms of each reaction rate are obtained
M.P. Dalwadi et al. / Journal of Theoretical Biology 439 (2018) 39–49 41 
Table 2 
Parameters. We use the value S 0 = 1 mM , and assume that E i = E j for i, j = 1 , . . . , 7 . Different values of E j can be considered by varying the appropriate dimensionless 
parameter. We introduce the small dimensionless parameter ε = 0 . 01 , to formally account for the large difference in magnitude between parameters, and choose A¯ = 1 in 
the simulations, as there is a distinguished asymptotic limit when A¯ = O (1) . 
Dimensional Organism Range 
k 1 = 10 s −1 Saccharomyces cerevisiae ( Kresze and Ronft, 1981a; 1981b ) 4 – 30 s −1 ( Kresze and Ronft, 1981a; 1981b; Snoep et al., 1992 ) 
k 2 = 200 s −1 Enterococcus faecalis ( Hedl et al., 2002 ) 10 – 260 s −1 ( Hedl et al., 2002; Matsumoto et al., 2013; Okamura et al., 2010 ) 
k −2 = 30 0 0 s −1 Enterococcus faecalis ( Hedl et al., 2002 ) 80 – 3600 s −1 ( Hedl et al., 2002; Reddick and Williams, 2008 ) 
k 3 = 6 s −1 Saccharomyces cerevisiae ( Middleton, 1972 ) 0.5 – 14 s −1 ( Middleton, 1972; Nagegowda et al., 2004; Sutherlin et al., 2002 ) 
k 4 = 10 s −1 Enterococcus faecalis ( Hedl et al., 2002 ) 1 – 20 s −1 ( Ching et al., 1996; Hedl et al., 2002; Ma et al., 2011 ) 
k 5 = 20 s −1 Methanosarcina mazei ( Primak et al., 2011 ) 4 – 40 s −1 ( Huang et al., 1999; Primak et al., 2011 ) 
k 6 = 4 s −1 Saccharomyces cerevisiae ( Garcia and Keasling, 2014 ) 2 – 6 s −1 ( Garcia and Keasling, 2014; Voynova et al., 2004 ) 
k 7 = 1 s −1 Saccharomyces cerevisiae ( Krepkiy and Miziorko, 2004 ) 0.1 – 5 . 5 s −1 ( Krepkiy and Miziorko, 2004; Qiu et al., 2007 ) 
K M 1 = 0 . 65 mM Saccharomyces cerevisiae ( Kresze and Ronft, 1981a ) 0.13 – 1 mM ( Kresze and Ronft, 1981a; Pronk et al., 1996; Snoep et al., 1992 ) 
K i 1 = 0 . 014 mM Saccharomyces cerevisiae ( Kresze and Ronft, 1981a ) 0.014 – 0.018 mM ( Kresze and Ronft, 1981a; Pronk et al., 1996 ) 
K M 2 = 1 mM Enterococcus faecalis ( Hedl et al., 2002 ) 0.06 – 1.2 mM ( Hedl et al., 2002; Matsumoto et al., 2013; Okamura et al., 2010 ) 
K M −2 = 0 . 01 mM Enterococcus faecalis ( Hedl et al., 2002 ) 0.01 – 0.09 mM ( Hedl et al., 2002; Reddick and Williams, 2008 ) 
K M 3 ,a = 0 . 015 mM Saccharomyces cerevisiae ( Middleton, 1972 ) 0.01 – 0.04 mM ( Middleton, 1972; Nagegowda et al., 2004; Sutherlin et al., 2002 ) 
K M 
3 ,b 
= 0 . 003 mM Saccharomyces cerevisiae ( Middleton, 1972 ) 0.0 0 01 – 0.01 mM ( Middleton, 1972; Nagegowda et al., 2004 ) 
K i 3 = 0 . 01 mM Saccharomyces cerevisiae ( Middleton, 1972 ) 0.008 – 0.02 mM ( Middleton, 1972; Nagegowda et al., 2004 ) 
K M 4 = 0 . 02 mM Enterococcus faecalis ( Hedl et al., 2002 ) 0.015 – 0.065 mM ( Ching et al., 1996; Hedl et al., 2002; Ma et al., 2011 ) 
K M 5 = 0 . 1 mM Methanosarcina mazei ( Primak et al., 2011 ) 0.06 – 0.24 mM ( Huang et al., 1999; Primak et al., 2011 ) 
K M 6 = 0 . 9 mM Saccharomyces cerevisiae ( Garcia and Keasling, 2014 ) 0.004 – 0.9 mM ( Garcia and Keasling, 2014; Voynova et al., 2004 ) 
K M 7 = 0 . 2 mM Saccharomyces cerevisiae ( Krepkiy and Miziorko, 2004 ) 0.03 – 0.9 mM ( Krepkiy and Miziorko, 2004; Qiu et al., 2007 ) 
A [s −1 ] 
Dimensionless parameters 
k¯ 2 = εk 2 E 2 /k 1 E 1 = 0 . 2 K¯ M 1 = K M 1 /S 0 = 0 . 65 K¯ M 4 = K M 4 /εS 0 = 2 
k¯ −2 = εk −2 E 2 /k 1 E 1 = 3 K¯ i 1 = K i 1 /εS 0 = 1 . 4 K¯ M 5 = K M 5 /S 0 = 0 . 1 
k¯ 3 = k 3 E 3 /k 1 E 1 = 0 . 6 K¯ M 2 = K M 2 /S 0 = 1 K¯ M 6 = K M 6 /S 0 = 0 . 9 
k¯ 4 = k 4 E 4 /k 1 E 1 = 1 K¯ M −2 = K M −2 /εS 0 = 1 K¯ M 7 = K M 7 /S 0 = 0 . 2 
k¯ 5 = k 5 E 5 /k 1 E 1 = 2 K¯ M 3 ,a = K M 3 ,a /εS 0 = 1 . 5 A¯ = AS 0 /k 1 E 1 = 1 
k¯ 6 = k 6 E 6 /k 1 E 1 = 0 . 4 K¯ M 3 ,b = K M 3 ,b /εS 0 = 0 . 3 
k¯ 7 = k 7 E 7 /k 1 E 1 = 0 . 1 K¯ i 3 = K i 3 /εS 0 = 1 
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p  rom the corresponding reference in Table 2 . The dimensional sys-
em is as follows 
d[ S 1 ] 
d τ
= − k 1 E 1 K 
i 
1 [ S 1 ] 
K i 
1 
(
[ S 1 ] + K M 1 
)
+ [ S 1 ][ S 2 ] 
, (2a) 
d[ S 2 ] 
d τ
= k 1 E 1 K 
i 
1 [ S 1 ] 
K i 
1 
(
[ S 1 ] + K M 1 
)
+[ S 1 ][ S 2 ] 
− k 2 E 2 [ S 2 ] 
[ S 2 ] + K M 2 
+ k −2 E 2 [ S 3 ] 
[ S 3 ] + K M −2 
−A [ S 2 ] , 
(2b) 
d[ S 3 ] 
d τ
= k 2 E 2 [ S 2 ] 
[ S 2 ] + K M 2 
− k −2 E 2 [ S 3 ] 
[ S 3 ] + K M −2 
− k 3 E 3 K 
i 
3 [ S 2 ][ S 3 ] 
K i 
3 
[ S 2 ][ S 3 ] + K M 3 ,a [ S 3 ] 
(
[ S 3 ] + K i 3 
)
+ K i 
3 
K M 
3 ,b 
[ S 2 ] 
, (2c) 
d[ S 4 ] 
d τ
= k 3 E 3 K 
i 
3 [ S 2 ][ S 3 ] 
K i 
3 
[ S 2 ][ S 3 ] + K M 3 ,a [ S 3 ] 
(
[ S 3 ] + K i 3 
)
+ K i 
3 
K M 
3 ,b 
[ S 2 ] 
− k 4 E 4 [ S 4 ] 
[ S 4 ] + K M 4 
,
(2d) 
d[ S 5 ] 
d τ
= k 4 E 4 [ S 4 ] 
[ S 4 ] + K M 4 
− k 5 E 5 [ S 5 ] 
[ S 5 ] + K M 5 
, (2e) 
d[ S 6 ] 
d τ
= k 5 E 5 [ S 5 ] 
[ S 5 ] + K M 5 
− k 6 E 6 [ S 6 ] 
[ S 6 ] + K M 6 
, (2f) 
d[ S 7 ] 
d τ
= k 6 [ S 6 ] 
[ S 6 ] + K M 6 
− k 7 E 7 [ S 7 ] 
[ S 7 ] + K M 7 
, (2g) 
d[ P ] 
d τ
= k 7 E 7 [ S 7 ] 
[ S 7 ] + K M 7 
. (2h) 
Most of the terms in the governing equations (2) are stan-
ard Michaelis–Menten reaction velocities, for which we obtainhe relevant kinetic parameters from the references indicated in
able 2 . The two modiﬁed Michaelis–Menten terms we include
re for reactions (1a) and (1d) , which describe different types of
nhibition. In Kresze and Ronft (1981a ), it is shown that acetyl-
oA has an inhibitory effect on (1a) which is uncompetitive with
yruvate. Therefore, for this reaction velocity we use the standard
orm for uncompetitive inhibition ( Yung-Chi and Prusoff, 1973 ).
n Middleton (1972) , it is shown that acetoacetyl-CoA has an in-
ibitory effect on (1d) which is competitive with acetyl-CoA, and
e therefore take this reaction velocity to have the standard form
or competitive inhibition, as stated in Middleton (1972) and Yung-
hi and Prusoff (1973) . The parameter A represents the total loss
f acetyl-CoA to other metabolic pathways, for example, the citric
cid cycle or fatty acid biosynthesis, and we assume that this oc-
urs with ﬁrst-order kinetics. While this parameter is diﬃcult to
easure experimentally, we will bypass this issue by considering
 distinguished limit in the dimensionless system when we per-
orm an asymptotic analysis. The parameters E i , where i = 1 , . . . , 7 ,
enote the enzyme concentrations for the reactions they control. 
We use initial conditions that correspond to the scenario where
yruvate is instantaneously introduced to a system containing all
f the relevant enzymes, but none of the intermediate metabolites.
hat is, we use [ S 1 ](0) = S 0 , [ S 2 ](0) = [ S 3 ](0) = [ S 4 ](0) = [ S 5 ](0) =
 S 6 ](0) = [ S 7 ](0) = [ P ](0) = 0 . Here, S 0 represents the initial or
ypical level of pyruvate present in the system. As any given
etabolite may already be present in the real-world system, our
pproach to the initial conditions is a modelling choice. That is,
e choose to reduce the number of uncertain parameters in the
ystem in order to facilitate a more simpliﬁed analysis of the sys-
em. 
To nondimensionalize the system variables, we scale each di-
ensional metabolite concentration with S 0 , the initial concentra-
ion of pyruvate. Additionally, we scale time with S 0 /( k 1 E 1 ), the
haracteristic time of the ﬁrst reaction, which occurs between
yruvate and acetyl-CoA. We summarise these scalings in Table 1 .
42 M.P. Dalwadi et al. / Journal of Theoretical Biology 439 (2018) 39–49 
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ε
 To form dimensionless parameters, we ﬁrst note that estimates of
the kinetic parameters can vary signiﬁcantly in different environ-
ments ( Table 2 ). Given the uncertainty in the parameters, we seek
to understand how the system behaves for different values of these
parameters; we seek asymptotic solutions in terms of the system
parameters, allowing us to explicitly determine how a variation in
parameter values affects the system. We can explore how the sys-
tem behaves as these parameters vary within an order of magni-
tude by ﬁrst scaling each rate constant with the rate constant of
the ﬁrst reaction, each Michaelis constant with the initial pyruvate
concentration, and each enzyme concentration with concentration
of the ﬁrst enzyme. Then, we use the typical dimensional values
in Table 2 to introduce an artiﬁcial small dimensionless parameter
ε = 0 . 01 into the system, and write each dimensionless parameter
as c  j , where c is an O (1) parameter (between 0.1 and 10), and j is
an integer. The resultant dimensionless parameters in our system
are given in Table 2 , and this approach allows us to interrogate
the system using an asymptotic analysis (see, for example, Hinch,
1991; Kevorkian and Cole, 2013; O’Malley, Jr., 2012 ). Although, as
is always the case with an asymptotic analysis, there may theo-
retically be an issue in equating terms with the same powers of
 when extreme O (1) parameters are multiplied together, we will
show that our asymptotic and numerical results show excellent
agreement, and thus the approach is reliable for this system. 
Therefore, we nondimensionalize using the dimensionless vari-
ables deﬁned in Table 1 and, using the dimensionless kinetic pa-
rameters deﬁned in Table 2 , we obtain the dimensionless system 
d S 1 
d t 
= − ε ¯K 
i 
1 S 1 
ε ¯K i 
1 
(
S 1 + K¯ M 1 
)
+ S 1 S 2 
, (3a)
d S 2 
d t 
= ε ¯K 
i 
1 S 1 
ε ¯K i 
1 
(
S 1 + K¯ M 1 
)
+ S 1 S 2 
− k¯ 2 S 2 
ε 
(
S 2 + K¯ M 2 
) + k¯ −2 S 3 
ε 
(
S 3 + ε ¯K M −2 
) − A¯ S 2 ,
(3b)
d S 3 
d t 
= k¯ 2 S 2 
ε 
(
S 2 + K¯ M 2 
) − k¯ −2 S 3 
ε 
(
S 3 + ε ¯K M −2 
)
− k¯ 3 ¯K 
i 
3 S 2 S 3 
K¯ i 
3 
S 2 S 3 + K¯ M 3 ,a S 3 
(
S 3 + ε ¯K i 3 
)
+ ε ¯K i 
3 
K¯ M 
3 ,b 
S 2 
, (3c)
d S 4 
d t 
= k¯ 3 ¯K 
i 
3 S 2 S 3 
K¯ i 
3 
S 2 S 3 + K¯ M 3 ,a S 3 
(
S 3 + ε ¯K i 3 
)
+ ε ¯K i 
3 
K¯ M 
3 ,b 
S 2 
− k¯ 4 S 4 
S 4 + ε ¯K M 4 
, (3d)
d S 5 
d t 
= k¯ 4 S 4 
S 4 + ε ¯K M 4 
− k¯ 5 S 5 
S 5 + K¯ M 5 
, (3e)
d S 6 
d t 
= k¯ 5 S 5 
S 5 + K¯ M 5 
− k¯ 6 S 6 
S 6 + K¯ M 6 
, (3f)
d S 7 
d t 
= k¯ 6 S 6 
S 6 + K¯ M 6 
− k¯ 7 S 7 
S 7 + K¯ M 7 
, (3g)
d P 
d t 
= k¯ 7 S 7 
S 7 + K¯ M 7 
. (3h)
In forming the dimensionless variables, we have used the
physically plausible value of S 0 = 1 mM . Finally, the initial con-
ditions become S 1 (0) = 1 , S 2 (0) = S 3 (0) = S 4 (0) = S 5 (0) = S 6 (0) =
S 7 (0) = P (0) = 0 . 
We solve this system for two cases. The ﬁrst case is where
(3a) does not hold and we instead impose S 1 ( t ) ≡1. This corre-
sponds to the scenario where pyruvate is continuously replenishednd held at a constant value. The second case is where (3a) does
old, and we will show that the two systems are equivalent for
 = O (1) . In both cases, we are interested in determining how to
aximise the production of IDP whilst minimizing the levels of
MG-CoA, linked to the inhibition of cell growth. 
. Solutions 
.1. Numerical results 
We solve the system presented in §2 numerically, using ode15s
n MATLAB with a relative tolerance of 10 −14 . We use the param-
ter values given in Table 2 for the continuous replenishment of
yruvate ( Fig. 2 ) and the no replenishment of pyruvate ( Fig. 3 )
ases. In each case, we are also able to model the over-expression
f an enzyme by increasing the dimensionless turnover numbers
the parameters denoted by a lower-case k with a subscript) given
n Table 2 . 
Although the dynamics for each case are different, we can ob-
erve general trends. Most notably, we see that increasing E 3 in-
reases both the maximum levels of HMG-CoA and of IDP pro-
uction, whereas increasing E 4 decreases the maximum levels of
MG-CoA but has a negligible affect on IDP production. Compar-
ng the continuously and never replenished pyruvate cases, we see
hat the initial dynamics appear to be similar between cases for
he same parameter values (until t ≈2 for HMG-CoA and t ≈12 for
DP), but the dynamics diverge after a longer time. In the contin-
ous replenishment case, the concentration of HMG-CoA and the
roduction rate of IDP tends to a constant value whereas, in the
o replenishment case, the concentration of HMG-CoA increases
o a maximum level before decreasing, and the concentration of
DP tends to a constant value. To understand these phenomena in
ore detail, and to determine how we can increase IDP production
hilst minimizing the maximum levels of (cell growth inhibiting)
MG-CoA in terms of the parameter values, we now perform an
symptotic analysis. 
.2. Asymptotic results 
.2.1. Continuous replenishment of pyruvate 
Here, we consider the system (3b–h), and impose S¯ 1 (t) ≡ 1 . As
he sink reaction (1c) is an amalgamation of all sinks of acetyl-
oA ( S 2 ), it is diﬃcult to obtain accurate estimates of A¯ . We pro-
eed by assuming the distinguished limit A¯ = O (1) , and we discuss
he further limit A¯ = O (1 /ε) in Appendix A . In pursuing an asymp-
otic analysis (see, for example, Hinch, 1991; Kevorkian and Cole,
013; O’Malley, Jr., 2012 ) for small , we make the following scal-
ngs: (S 2 , S 5 , S 6 , S 7 , P ) = ε 1 / 2 ( ¯S 2 , S¯ 5 , S¯ 6 , S¯ 7 , P¯ ) , (S 3 , S 4 ) = ε 3 / 2 ( ¯S 3 , S¯ 4 )
nd we obtain the t = O (1) governing equations 
 
d ¯S 2 
d t 
= ε ¯K 
i 
1 S¯ 1 
ε 1 / 2 K¯ i 
1 
(
S¯ 1 + K¯ M 1 
)
+ S¯ 1 ¯S 2 
− k¯ 2 ¯S 2 
ε 1 / 2 S¯ 2 + K¯ M 2 
+ k¯ −2 ¯S 3 
ε 1 / 2 S¯ 3 + K¯ M −2 
− ε ¯A ¯S 2 , (4a)
 
2 d ¯S 3 
d t 
= k¯ 2 ¯S 2 
ε 1 / 2 S¯ 2 + K¯ M 2 
− k¯ −2 ¯S 3 
ε 1 / 2 S¯ 3 + K¯ M −2 
− ε ¯k 3 ¯K 
i 
3 S¯ 2 ¯S 3 
ε 1 / 2 K¯ i 
3 
S¯ 2 ¯S 3 + ε ¯K M 3 ,a S¯ 3 
(
ε 1 / 2 S¯ 3 + K¯ i 3 
)
+ K¯ i 
3 
K¯ M 
3 ,b 
S¯ 2 
, (4b)
 
d ¯S 4 
d t 
= k¯ 3 ¯K 
i 
3 S¯ 2 ¯S 3 
ε 1 / 2 K¯ i 
3 
S¯ 2 ¯S 3 + ε ¯K M 3 ,a S¯ 3 
(
ε 1 / 2 S¯ 3 + ¯K i 3 
)
+ ¯K i 
3 
K¯ M 
3 ,b 
S¯ 2 
− k¯ 4 ¯S 4 
ε 1 / 2 S¯ 4 + ¯K M 4 
, 
(4c)
M.P. Dalwadi et al. / Journal of Theoretical Biology 439 (2018) 39–49 43 
Fig. 2. The numerically determined concentrations of (a) HMG-CoA and (b) IDP in the continuous replenishment of pyruvate case. The solid black lines denote the solutions 
using the reference parameter values given in Table 2 with E i = E j for i = j , and the dashed lines denote the solutions when a particular enzyme is over-expressed. The 
solutions when E 2 , E 5 , E 6 , or E 7 are doubled are near identical to the reference concentration in (a). The solutions when E 2 , E 4 , or E 5 are doubled are near identical to the 
reference concentration in (b), and the solutions when E 6 or E 7 are doubled are near identical to each other. 
Fig. 3. The numerically determined concentrations of (a) HMG-CoA and (b) IDP in the no replenishment of pyruvate case. The solid black lines denote the solutions using 
the parameter values given in Table 2 with E i = E j for i = j , and the dashed lines denote the solutions when a particular enzyme is over-expressed. The solutions when E 2 , E 5 , 
E 6 , or E 7 are doubled are near identical to the reference concentration in (a). The solutions when E 2 , E 4 , or E 5 are doubled are near identical to the reference concentration 
in (b), and the solutions when E 6 or E 7 are doubled are near identical to each other. We see that the solutions in this no replenishment of pyruvate case are very similar to 
the solutions in the continuous replenishment of pyruvate case until t ≈2 for HMG-CoA and until t ≈12 for IDP. 
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f  d ¯S 5 
d t 
= k¯ 4 ¯S 4 
ε 1 / 2 S¯ 4 + K¯ M 4 
− k¯ 5 ¯S 5 
ε 1 / 2 S¯ 5 + K¯ M 5 
, (4d) 
d ¯S 6 
d t 
= k¯ 5 ¯S 5 
ε 1 / 2 S¯ 5 + K¯ M 5 
− k¯ 6 ¯S 6 
ε 1 / 2 S¯ 6 + K¯ M 6 
, (4e) 
d ¯S 7 
d t 
= k¯ 6 ¯S 6 
ε 1 / 2 S¯ 6 + K¯ M 6 
− k¯ 7 ¯S 7 
ε 1 / 2 S¯ 7 + K¯ M 7 
, (4f) 
d ¯P 
d t 
= k¯ 7 ¯S 7 
ε 1 / 2 S¯ 7 + K¯ M 7 
. (4g) 
The leading-order version of (4) is given by 
d ¯S 2 
d t 
= K¯ 
i 
1 
S¯ 2 
− v 3 ¯S 3 − A¯ ¯S 2 , 0 = v 2 ¯S 2 − v −2 ¯S 3 , 0 = v 3 ¯S 3 − v 4 ¯S 4 , 
d ¯S 5 
d t 
= v 4 ¯S 4 − v 5 ¯S 5 , d ¯S 6 
d t 
= v 5 ¯S 5 − v 6 ¯S 6 , d ¯S 7 
d t 
= v 6 ¯S 6 − v 7 ¯S 7 , 
d ¯P 
d t 
= v 7 ¯S 7 , (5) 
here v j = k j /K M j for j ∈ { 2 , −2 , 4 , 5 , 6 , 7 } , and v 3 = k¯ 3 / ¯K M 3 ,b , and
5) is solved by 
¯
 2 = 
( 
K¯ i 1 
(
1 − e −2 αt 
)
α
) 1 / 2 
, S¯ 3 = v 2 v −2 
S¯ 2 , S¯ 4 = v 2 v 3 v −2 v 4 
S¯ 2 , ¯
 5 = v 2 v 3 v −2 
∫ t 
0 
e v 5 (s −t) S¯ 2 (s ) d s, 
¯
 6 = v 2 v 3 v 5 v −2 
∫ t 
0 
e v 5 (s −t) − e v 6 (s −t) 
v 6 − v 5 
S¯ 2 (s ) d s, 
¯
 7 = v 2 v 3 v 5 v 6 v −2 
∫ t 
0 
( v 7 − v 6 ) e v 5 (s −t) − ( v 7 − v 5 ) e v 6 (s −t) + ( v 6 − v 5 ) e v 7 (s −t) 
( v 7 − v 6 ) ( v 7 − v 5 ) ( v 6 − v 5 ) 
S¯ 2 (s ) d s, 
P¯ = v 2 v 3 v 5 v 6 v 7 
v −2 
×
∫ t 
0 
v 7 − v 6 
v 5 
(
1 − e v 5 (s −t) 
)
− v 7 − v 5 
v 6 
(
1 − e v 6 (s −t) 
)
+ v 6 − v 5 
v 7 
(
1 − e v 7 (s −t) 
)
( v 7 − v 6 ) ( v 7 − v 5 ) ( v 6 − v 5 ) 
S¯ 2 (s ) d s. 
(6) 
here α = A¯ + v 2 v 3 / v −2 . We see that these asymptotic solutions
gree well with the numerical ones, except at early time where
here is an additional asymptotic region that we do not consider
 Fig. 4 ). 
Although the leading-order solution for P¯ , given in (6) , depends
n parameters from almost all of the reactions, the dependence on
 5 , v 6 , and v 7 is signiﬁcantly reduced as t → ∞ , and we may deter-
ine that the leading-order long-time behaviour in this regime is
iven by 
 ¯∼ v 2 v 3 
v −2 
(
K¯ i 1 
α
)1 / 2 
t as t → ∞ . (7) 
ence, the reactions involving acetyl-CoA are the most important
or the production of IDP. We can see that the numerical results
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Fig. 4. The numerical and asymptotic solutions for the metabolite concentrations in the continuous replenishment of pyruvate case. The solid light lines denote the numerical 
solutions, and the dashed darker lines denote the asymptotic solutions given in (6) . We see good agreement between the numerical and asymptotic solutions for t = O (1) , 
and the system attains its steady state solution in this region. 
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[  shown in Fig. 4 b agree with the analytic result that P¯ tends to
a linear function of time. We may also deduce the leading-order
long-time behaviour of HMG-CoA in the form 
S¯ 4 → v 2 v 3 v −2 v 4 
(
K¯ i 1 
α
)1 / 2 
as t → ∞ . (8)
In dimensional terms, the long-time behaviour of the isopen-
tenyl diphosphate (IDP) concentration is 
[ P ] ∼ ωE 3 
(
E 1 k 1 K 
i 
1 
A + ωE 3 
)1 / 2 
τ as τ → ∞ , (9a)
and the maximum level of HMG-CoA present in the system is 
[ S 4 ] ∼
ωE 3 K 
M 
4 
k 4 E 4 
(
E 1 k 1 K 
i 
1 
A + ωE 3 
)1 / 2 
, (9b)
where 
ω = k 2 k 3 K 
M 
−2 
k −2 K M 2 K 
M 
3 ,b 
. (9c)
From the explicit results (9), we see that the long-time pro-
duction of IDP depends on the enzyme concentrations E 1 and E 3 ,
whereas the maximum concentration of HMG-CoA depends on the
enzyme concentrations E 1 , E 3 , and E 4 . Recalling that our goal is
to maximize IDP whilst minimizing HMG-CoA, and noting that the
dependence on E 1 and E 3 is the same for both metabolites of in-
terest, the only way our goal can be achieved by varying enzyme
concentration is to signiﬁcantly increase E 4 , so that it compen-
sates for any increase in E 1 or E 3 . That is, our model suggests
that we should overexpress HMG-CoA reductase, the enzyme that
catalyses the reaction from HMG-CoA to mevalonate. Importantly,
we are able to deduce that this is the most signiﬁcant leading-
order effect, and this explicit result is possible due to our asymp-
totic analysis. The signiﬁcance of this reaction is in agreement with
Pitera et al. (2007) , where it was shown that over-expression of
HMG-CoA reductase alleviated the inhibition of cell growth, bene-
ﬁting IDP production. Increasing E 3 , the enzyme that catalyses the
reaction from acetoacetyl-CoA and acetyl-CoA to HMG-CoA would
increase the levels of IDP produced by a single cell, but would also
produce more HMG-CoA, which would reduce the number of cells
in the system (though this is not formally taken into account by
our model). The same is true of increasing E 1 , the enzyme that
catalyses the reaction from pyruvate to acetyl-CoA, and decreasing
A , any enzyme that catalyses reactions from acetyl-CoA to sinks of
acetyl-CoA. Finally, we note that these results all agree with the
numerical results in Fig. 2 . 
w.2.2. No replenishment of pyruvate 
We now consider the case where pyruvate can be depleted.
ote that this case, unlike the previous, is singularly perturbed on
he long timescale. From (3a) , we must also consider the governing
quation 
d ¯S 1 
d t 
= − ε 
1 / 2 K¯ i 1 S¯ 1 
ε 1 / 2 K¯ i 
1 
(
S¯ 1 + K¯ M 1 
)
+ S¯ 1 ¯S 2 
, (10)
nstead of imposing S¯ 1 (t) ≡ 1 . By seeking a power series represen-
ation for S¯ 1 in terms of the small parameter 
1/2 , and using the
olution ( 6 a) for S¯ 2 , we obtain the following asymptotic solution
o (10) for t = O (1) : 
¯
 1 (t) ∼ 1 −
(
ε ¯K i 1 
α
)1 / 2 (
αt + log 
{ 
1 + 
[
1 − e −2 αt 
]1 / 2 } )+ O (ε) . 
(11)
mportantly, we ﬁnd that S¯ 1 (t) ∼ 1 + O (ε 1 / 2 ) for t = O (1) , and
hus the no replenishment case is equivalent to the continuous re-
lenishment case at leading order for t = O (1) . 
As suggested by (11) , the O (1) decay of pyruvate occurs over the
imescale t = O (ε −1 / 2 ) . Further, as the dominant balances over this
imescale do not change, the solution (11) allows us to deduce that
he depletion of pyruvate occurs when 
 
∗ = 1 / (εαK¯ i 1 ) 1 / 2 + O (1) . (12)
For completion, we show the dynamics of this depletion, where
he levels of pyruvate become exponentially small, in Appendix B .
sing the depletion time (12) in the long-time IDP solution (7) and
everting back to the original unscaled version of IDP, we deter-
ine that the total amount of IDP produced in the no replenish-
ent of pyruvate case is 
lim 
→∞ 
P = v 2 v 3 
αv −2 
+ O (ε 1 / 2 ) . (13)
urther, we may deduce that the maximum level of HMG-CoA in
he system is again given by (8) . In dimensional terms, the long-
ime behaviour of the isopentenyl diphosphate (IDP) concentration
s 
 P ] ∼ ωS 0 E 3 
A + ωE 3 
as τ → ∞ , (14)
nd the maximum level of HMG-CoA present in the system is 
 S 4 ] ∼
ωE 3 K 
M 
4 
k 4 E 4 
(
E 1 k 1 K 
i 
1 
A + ωE 3 
)1 / 2 
, (15)
here ω is deﬁned in (9 c ). 
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Fig. 5. Experimental results for (a) mevalonate production by C. necator H16/pBBR1JW3 (pBBR1:: araC /P BAD - mvaES ) after 24 hours of growth in 1% (w/v) fructose minimal 
medium (FMM) in response to the following L -arabinose concentrations: 0.01% (w/v - grey bar); 0.02% (w/v - dark grey bar); and 0.2% (w/v - light grey bar). As a negative 
control, mevalonate production was assessed also with the C. necator H16/pBBR1-USERcassette1 strain (empty vector), that does not harbour the mvaE and mvaS genes. (b) 
SDS-PAGE of pre- (lane 1) and post-induction protein extracts of C. necator H16/pBBR1JW3. Expression of MvaE (86 KDa) and MvaS (42 KDa) was assessed following induction 
with 0.01% (lane 2); 0.02% (lane 3); and 0.2% (lane 4) L -arabinose. While MvaE expression levels increased with increasing L -arabinose concentrations, production of MvaS 
appeared to remain constant. 
Fig. 6. Schematic showing how overexpression of enzymes can affect IDP production in the cases of pyruvate being (a) continuously replenished and (b) never replenished. 
The green arrows denote that overexpressing the enzyme corresponding to that reaction results in greater production of IDP with diminishing returns. A dashed or dotted 
arrow denotes whether these diminishing returns are unbounded or bounded, respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is 
referred to the web version of this article.) 
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p 1 5 Hence, our main conclusions from the continuous replenish-
ent case are still valid for this case. For this no-replenishment-of-
yruvate case, we are also able to further determine that a lower
alue of K i 
1 
, perhaps achievable by introducing heterologous en-
ymes for the reaction (1a) , would decrease the maximum amount
f HMG-CoA present whilst having no signiﬁcant effect on the total
DP produced. 
. Experimental validation 
To validate the predictions made in this model, we carried
ut in vivo experiments in Cupriavidus necator H16, a gram-
egative bacterium previously known as Ralstonia eutropha. C.
ecator is a facultative chemolithoautotrophic microorganism of
elevant biotechnological interest since it can be exploited as a
acterial chassis for the production of chemicals. As proof of con-ept, we sought to introduce the upper part of the mevalonate
athway, leading to the production of isoprenoid precursors, into C.
ecator . To this end, C. necator H16 was transformed with a plas-
id (pBBR1JW3) carrying the mvaE and mvaS genes from E. fae-
alis of the L -arabinose inducible promoter P BAD . These two genes
ode for the enzymes Acetyl-CoA acetyltransferase/HMG-CoA re-
uctase (MvaE) and Hydroxymethylglutaryl-CoA synthase (MvaS),
espectively. MvaE is a bifunctional enzyme that catalyses two re-
ctions, from acetyl-CoA to acetoacetyl-CoA and from HMG-CoA
o mevalonate, while MvaS converts acetoacetyl-CoA and acetyl-
oA to HMG-CoA. In our model, increasing the expression of MvaE
orresponds to increasing E 2 and E 4 , whereas increasing the ex-
ression of MvaS corresponds to increasing E 3 (a schematic of the
athway is shown in Fig. 1 ). This plasmid provides a path from
yruvate to mevalonate ( S to S ) within the modiﬁed C. necator . 
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Fig. 7. Schematic showing how overexpression of enzymes can affect levels of HMG-CoA. A green/red arrow denotes that overexpressing the enzyme corresponding to that 
reaction results in greater/lesser amounts of HMG-CoA, and a dashed arrow denotes that over-expression results in unbounded but diminishing returns. The results are the 
same for the cases of pyruvate being continuously and never replenished. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the 
web version of this article.) 
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F4.1. Setting up of bacterial cultures for mevalonate production 
Single colonies of C. necator H16/pBBR1-USERcassette1 and C.
necator H16/pBBR1JW3 (pBBR1:: araC /P BAD - mvaES ) were used to in-
oculate 5ml of LB solution with 300μg/ml kanamycin (in 50ml
tubes) and grown overnight at 30 °C with shaking (200 rpm). The
following morning, the optical density (OD 600 ) of the cultures was
measured and normalised to OD 600 = 0 . 2 in 100ml of LB solution
with 300μg/ml kanamycin (in 500ml ﬂasks). The bacterial cultures
were then incubated at 30 °C with shaking (200 rpm) until they
reached an OD 600 of around 0.6 - 0.7. At this point, 1ml samples
were collected from each culture, centrifuged at 140 0 0 rpm for one
minute and the cell pellets were stored at -20 °C to be used as
pre-induction protein samples for SDS-PAGE. In addition, 1ml of 1%
(w/v); 2% (w/v); or 20% (w/v) L -arabinose solutions were added to
the corresponding cultures, thus obtaining L -arabinose ﬁnal con-
centrations of 0.01%; 0.02%; and 0.2%, respectively. Following 18
hours of incubation at 30 °C with shaking (200 rpm), the OD 600 of
the cultures was measured. The bacterial cultures were then cen-
trifuged (80 0 0 rpm for ﬁve minutes), concentrated to OD 600 = 15
in 1% fructose minimal medium (FMM) –NH 4 Cl with 300μg/ml
kanamycin and transferred to 250ml ﬂasks. After 24 hours of incu-
bation at 30 °C with shaking (20 0 rpm), 50 0μl samples were taken
from the cultures and centrifuged (140 0 0 rpm for one minute). Su-
pernatants were then analysed by HPLC to quantify the mevalonate
titres produced by C. necator H16/pBBR1JW3 in response to the dif-
ferent L -arabinose concentrations taken into account. 
4.2. Model comparison 
We can use our model to predict the behaviour of the
shorter pathway from pyruvate to mevalonate, by taking the limit
k¯ 5 , ¯k 6 , ¯k 7 → 0 . In this case, the results for [ S 4 ] remain the same
and, in dimensional terms, the long-time results for [ S 5 ] are 
[ S 5 ] ∼ ωE 3 
(
E 1 k 1 K 
i 
1 
A + ωE 3 
)1 / 2 
τ as τ → ∞ , (16)
for continuous replenishment of pyruvate and 
[ S 5 ] → ωS 0 E 3 
A + ωE 3 
as τ → ∞ , (17)
for no replenishment of pyruvate, where ω =
k 2 k 3 K 
M 
−2 / (k −2 K 
M 
2 K 
M 
3 ,b 
) , as previously deﬁned in (9c) . All vari-
ables are deﬁned in §2 . These are the same results our model
predicts for [ P ], so our previous predictions for maximizing IDP
while minimizing HMG-CoA will also be our current predictions
for maximizing mevalonate while minimizing HMG-CoA in this
experiment. 
HPLC data show that increasing the concentration of the in-
ducer L -arabinose leads to signiﬁcant increments in the amount of
mevalonate produced after 24 hours of growth in the presence ofructose as a carbon source ( Fig. 5 a). From the three levels of L -
rabinose we considered, there appear to be diminishing returns
n the effectiveness of increasing L -arabinose. From an SDS-PAGE,
e see an increase in the expression of MvaE as the levels of L -
rabinose are increased ( Fig. 5 b). However, production of MvaS ap-
ears to be constant as the levels of L -arabinose are increased. In
ur model, this corresponds to increasing E 2 and E 4 while keep-
ng E 3 (and all other enzyme levels) constant. As discussed above,
ur model predicts that this will decrease the maximum levels of
MG-CoA in the system, and thus produce more IDP. Hence, our
odel is veriﬁed by these experimental results. 
. Conclusions 
We developed and solved a mathematical model for the kinetics
f the mevalonate pathway, derived using generalised Michaelis–
enten kinetics and including the effect of a sink from acetyl-CoA
nto other metabolic pathways. We considered two extreme cases,
amely where the pyruvate was continuously and never replen-
shed. We used asymptotic analysis to gain physical insight into the
ystem behaviour, allowing us to evaluate the effect of upregulat-
ng different reactions without resorting to an expensive parameter
weep. The system we considered here has eight dependent vari-
bles with 20 kinetic parameters. Our asymptotic analysis enabled
s to give analytic expressions for each dependent variable in the
ontinuous replenishment case, and to reduce the entire system to
umerically solving a coupled nonlinear system of two dependent
ariables with one parameter in the never replenished case. We
hen validated our model by performing experiments that agreed
ith our predictions. 
The main experimental goal is to maximise IDP production,
hilst minimizing the maximum levels of HMG-CoA, a metabo-
ite that is linked to the inhibition of cell growth due to its in-
ibition of fatty acid biosynthesis ( Kizer et al., 2008 ). In terms of
ver-expressing enzymes, we see that over-expressing E 3 , the en-
yme that catalyses the reaction from acetoacetyl-CoA and acetyl-
oA to HMG-CoA will have a positive effect on both IDP produc-
ion and maximum levels of HMG-CoA. Thus, over-expressing this
nzyme by itself will not have signiﬁcant effects. However, we ad-
itionally note that over-expressing E 4 , the enzyme that catalyses
he reaction from HMG-CoA to mevalonate, will decrease the lev-
ls of HMG-CoA without having a signiﬁcant effect on IDP pro-
uction. Therefore, over-expressing both E 3 and E 4 should have a
uch larger effect on IDP production than just over-expressing E 3 .
he importance of the reaction from HMG-CoA to mevalonate has
een previously noted by experiments ( Pitera et al., 2007 ). We also
ote that increasing E 1 has a positive effect on both IDP production
or continuously replenished pyruvate, and on the maximum levels
f HMG-CoA. Thus, as for E 3 , this effect can be ampliﬁed by also
ver-expressing E 4 at the same time. We illustrate these results in
igs. 6 and 7 . 
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(Our results also suggest that the reactions between acetyl-CoA
nd acetoacetyl-CoA can have a signiﬁcant effect on both IDP pro-
uction and maximum levels of HMG-CoA. However, this effect
annot be achieved by over- or under-expressing E 2 , the enzyme
hat catalyses this reaction, as the enzyme catalyses the reaction in
oth directions. We see that this positive effect can be attained by
sing an enzyme that strongly favours the forward reaction. That
s, an enzyme with a large ratio of k 2 K 
M 
−2 /k −2 K 
M 
2 . The ﬁnal reaction
hat plays an important role at leading order is the reaction from
cetyl-CoA to a sink, which has a negative leading-order effect on
oth IDP production and the maximum levels of HMG-CoA. Al-
hough we consider the dimensionless sink coeﬃcient to be of O (1)
n our main analysis, we also show in Appendix A that a large sink
oeﬃcient does not signiﬁcantly affect the system behaviour. How-
ver, we note that the importance of acetyl-CoA to other metabolic
athways represented by this sink, such as the citric acid cycle,
eans that there are likely to be negative effects to the cell if this
eaction is signiﬁcantly altered. Our results suggest that the reac-
ions and enzymes we have mentioned are the only signiﬁcant re-
ctions at leading order, and we predict that the over-expression
f other enzymes in the pathway will not have a signiﬁcant effect
n either IDP production or on the maximum levels of HMG-CoA. 
In the case where pyruvate was never replenished, we found
hat the depletion of pyruvate occurred slowly enough that, for
ntermediate time, our system reproduced the steady-state be-
aviour we would eventually expect from the continuously replen-
shed pyruvate case. However, whilst the system was initially ro-
ust to this slow depletion, we additionally calculated the point at
hich the low levels of pyruvate affected the entire system, then
alculated the dynamics of this depletion. This required the use of
he method of matched asymptotic expansions with logarithmic
atching terms involving the small variable to track metabolite
oncentrations up to the ﬁrst correction order over two timescales,
hus allowing us to obtain the leading-order depletion at the third
nd ﬁnal timescale. 
In our experiments, we were able to introduce a pathway from
yruvate to mevalonate into the bacterium C. necator . This was
chieved by transforming C. necator with a plasmid harbouring the
. faecalis mvaE and mvaS genes under the control of a promoter
nduced by the presence of L -arabinose (P BAD ). The proteins MvaE
nd MvaS, respectively encoded by these two genes, are responsi-
le for the conversion of acetyl-CoA to mevalonate. A protein ex-
ression analysis showed that production of MvaE increased as the
evels of L -arabinose present in the cultivation medium were in-
reased. On the other hand, expression of MvaS appeared to be
ndependent of L -arabinose concentration. In any case, the effect
f increasing MvaE expression was to produce more mevalonate,
n experimental result that agreed with the theoretical predictions
rom our model. We note that our model could be veriﬁed fur-
her by directly measuring the levels of HMG-CoA. However, as
MG-CoA is not secreted by the cell and is likely to be unstable,
irect measurement is signiﬁcantly more technical; as carried out
n Pitera et al. (2007) , the experiments would have to be repeated
hile rapidly quenching the cellular metabolism, before examining
he endo-metabolites using mass spectrometry. 
In the derivation of this model, we chose initial conditions that
odelled the instantaneous addition of pyruvate to a well-mixed
olution of enzymes. These conditions were chosen for mathemat-
cal convenience and are likely to differ signiﬁcantly from the con-
itions within a cell producing isopentenyl-diphosphate. However,
s the systems we have considered both tend to stable steady
tates, this difference is unlikely to be a practical issue for the long
ime results, although it would affect the initial transients. 
Finally, we note that this work highlights how a simple mathe-
atical model can be used to predict the biologically relevant be-
aviour of a system. Moreover, this work shows how asymptoticnalysis can play an important role in reducing the computational
omplexity of a derived system and be used to overcome uncer-
ainty issues with parameter values. We hope that the predictions
rom our model can help to build a more eﬃcient path to biologi-
al discovery. 
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ppendix A. Large A¯ limit 
There is another distinguished limit in the system (3) when A¯ =
 (1 /ε) . We brieﬂy summarise the system behaviour in this limit
or t = O (1) . The leading-order system (5) is mainly unchanged,
part from the ﬁrst equation for S¯ 2 , which becomes 
ε ¯K i 1 S 1 
ε 1 / 2 K¯ i 
1 
(
S 1 + K¯ M 1 
)
+ S 1 S 2 
= ε ¯A S 2 , (A.1) 
here we now have S 2 = O (ε 1 / 2 ) , providing an asymptotic balance
etween the two terms. Rearranging (A.1) for S 2 in terms of S 1 , we
btain 
 2 = ε 
1 / 2 
2 
⎡ 
⎣ 
{ (
K¯ i 1 (S 1 + K¯ M 1 ) 
S 1 
)2 
+ 4 ¯K 
i 
1 
ε ¯A 
} 1 / 2 
−
K¯ i 1 
(
S 1 + K¯ M 1 
)
S 1 
⎤ 
⎦ . 
(A.2) 
or the continuous-replenishment case we have S 1 ( t ) ≡1, and for
he no-replenishment case the governing equation for S 1 is given
y (10) . Finally, focusing on the continuous-replenishment case, we
ote that we can re-write (7) , the long-time production of IDP, as 
 ¯∼
(v 2 v 3 
v −2 
t 
)
lim 
t→∞ 
S 2 (t) as t → ∞ . (A.3) 
hus, from (A.2) we see that the long-time production of IDP gains
ome further dependence on the kinetic properties of E 1 in the
imit of large A¯ , but retains the same qualitative behaviour. 
ppendix B. Dynamics of pyruvate depletion 
In this appendix, we further investigate the dynamics of pyru-
ate depletion. We only investigate S¯ 1 and S¯ 2 here, as the leading-
rder versions of the remaining metabolites can be obtained by
uitably rescaling the solutions ( 6 b–g) for the timescales we
resent in this appendix. 
To obtain the leading-order solutions during the important
epletion timescale, we require the long-time behaviour of the
 ( 1/2 ) correction to S¯ 2 at t = O (1) . To this end, we may use the
eading-order solution (6) to write the asymptotic expansion 
¯
 2 ∼
( 
K¯ i 1 
(
1 − e −2 αt 
)
α
) 1 / 2 
+ ε 1 / 2 K¯ i 1 s 2 (t) as ε → 0 , (B.1) 
here s 2 (t) = O (1) is the ﬁrst correction term for S¯ 2 . We combine
4a,b), (11) , and (B.1) to obtain 
1 
α
d s 2 
d t 
+ 
(
2 − e −2 αt 
1 − e −2 αt 
)
s 2 = 2 β
1 − e −2 αt + 2 γ
(
1 − e −2 αt 
)
, (B.2a) 
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Fig. B.1. The solutions to the full and reduced systems for the concentrations of S 1 and S 2 in the no replenishment of pyruvate case. We show (a) A linear plot (b) A log-lin 
plot. The solid light lines denote the numerical solutions to the full problem, and the dashed darker lines denote the solutions to the reduced problem given in (B.8). We 
see good agreement between the numerical and asymptotic solutions apart from at early time, as we expect. 
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β = − K¯ 
M 
1 + 1 
2 
, (B.2b)
γ = v 2 v 3 
2 α2 v −2 
(
1 
K¯ M 
2 
− v 2 
k¯ −2 
+ v 2 v 3 
v −2 ¯k 3 
)
. (B.2c)
Solving (B.2a) in the long-time limit, we deduce that 
s 2 ∼ β + γ + exponentially small terms as t → ∞ , (B.3)
and thus we are able to determine the long-time behaviour 
S¯ 2 ∼
(
K¯ i 1 
α
)1 / 2 
+ ε 1 / 2 K¯ i 1 ( β + γ ) as t → ∞ . (B.4)
The O (1) depletion of pyruvate occurs over the timescale t =
O (ε −1 / 2 ) , and we investigate this using the scaling t = T /ε 1 / 2 ,
where T = O (1) . Writing S¯ 1 and S¯ 2 as the asymptotic expansions 
S¯ 1 ∼ S¯ (0) 1 + ε 1 / 2 S¯ (1) 1 , S¯ 2 ∼ S¯ (0) 2 + ε 1 / 2 S¯ (1) 2 as ε → 0 , (B.5)
the appropriate governing equations, obtained from (10) and (4a,b),
are 
d ¯S (0) 
1 
d T 
= − K¯ 
i 
1 
S¯ (0) 
2 
, (B.6a)
d ¯S (1) 
1 
d T 
= K¯ 
i 
1 (
S¯ (0) 
2 
)2 
(
S¯ (1) 
2 
+ K¯ i 1 
(
1 + K¯ 
M 
1 
S¯ (0) 
1 
))
, (B.6b)
0 = K¯ 
i 
1 
S¯ (0) 
2 
− αS¯ (0) 
2 
, (B.6c)
d ¯S (0) 
2 
d T 
= −2 α
(
S¯ (1) 
2 
+ K¯ i 1 
(
1 
2 
(
1 + K¯ 
M 
1 
S¯ (0) 
1 
)
− γ
))
, (B.6d)
with matching conditions, valid when T → 0 + , 
S¯ (0) 
1 
∼ 1 −
(
αK¯ i 1 
)1 / 2 
T , S¯ (1) 
1 
∼ −
(
K¯ i 1 
α
)1 / 2 
log 2 , 
S¯ (0) 
2 
∼
(
K¯ i 1 
α
)1 / 2 
, S¯ (1) 
2 
∼ K¯ i 1 ( β + γ ) , (B.6e)
obtained using Van Dyke’s matching rule ( van Dyke, 1975 ) on the
 = O (1) results (11) and (B.4) . The system (B.6) is thus solved by 
¯
 
(0) 
1 
= 1 −
(
αK¯ i 1 
)1 / 2 
T , (B.7a)
¯
 
(1) 
1 
= αK¯ i 1 
(
γ + 1 
2 
)
T −
K¯ M 1 
(
αK¯ i 1 
)1 / 2 
2 
log 
(
1 −
(
αK¯ i 1 
)1 / 2 
T 
)
−
(
K¯ i 1 
α
)1 / 2 
log 2 , (B.7b)
¯
 
(0) 
2 
= 
(
K¯ i 1 
α
)1 / 2 
, (B.7c)
¯
 
(1) 
2 
= K¯ i 1 
⎛ 
⎝ β + γ − (αK¯ i 1 )1 / 2 T 
2 
(
1 −
(
αK¯ i 
1 
)1 / 2 
T 
)
⎞ 
⎠ . (B.7d)
The most signiﬁcant asymptotic regime of interest for the
epletion dynamics occurs when S¯ 1 = O (ε 1 / 2 ) , which results in
he depletion of several metabolites in the system. This re-
ion occurs when t = 1 / (εαK¯ i 
1 
) 1 / 2 + ˆ  t/α (equivalently, when T =
 / (αK¯ i 
1 
) 1 / 2 + ε 1 / 2 ( ˆ t/α) ), where ˆ t = O (1) . We additionally scale
( ¯S 1 , S¯ 2 ) = ( ¯K i 1 /α) 1 / 2 (ε 1 / 2 ˆ S 1 ( ˆ t) , ˆ  S 2 ( ˆ t)) . Substituting these scalings
nto (10) and (4a,b) results in the leading-order long-time equa-
ions 
d ˆ  S 1 
d ˆ t
= −
ˆ S 1 
αK¯ M 
1 
+ ˆ S 1 ˆ  S 2 
, (B.8a)
d ˆ  S 2 
d ˆ t
= 
ˆ S 1 
αK¯ M 
1 
+ ˆ S 1 ˆ  S 2 
− ˆ S 2 . (B.8b)
The leading-order matching conditions as ˆ t → −∞ are ˆ S 1 ∼ −tˆ
nd ˆ S 2 → 1 , and the remaining variables in the system are still
iven by ( 6 c-h). In practice, we ﬁnd that this leading-order system
s sensitive to the O ( 1/2 ) matching condition for ˆ S 1 as ˆ t → −∞ .
e can deduce this directly by determining the behaviour of ˆ S 1 as
ˆ → −∞ from the system (B.8). That is, we deduce that 
ˆ 
 1 ∼ −ˆ t − (αK¯ M 1 / 2) log (−ˆ t) + C as ˆ t → −∞ . (B.9a)
e may determine C by matching the solution to S¯ 1 up to O ( 
1/2 )
hen t = O (ε −1 / 2 ) , given in (B.7a,b). From this matching, we de-
uce that 
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  = − log 2 + 1 
2 
(
v 2 v 3 
αv −2 
(
1 
K¯ M 
2 
− v 2 
k −2 
+ v 2 v 3 
k 3 v −2 
)
+ α
)
− αK¯ 
M 
1 
4 
log 
(
ε ¯K i 1 
α
)
+ O (ε 1 / 2 ) . (B.9b) 
Using (B.9) as the matching condition for ˆ S 1 , we may numer-
cally solve (B.8) to obtain the depletion dynamics for ˆ S 1 and ˆ S 2 ,
hen use the latter solution in ( 6 b–g) to deduce the depletion
ynamics for the remaining metabolites. We see excellent agree-
ent between these asymptotically determined solutions and the
ull numerical solutions ( Fig. B.1 ). 
As the system (B.8) is governed by two coupled autonomous
onlinear equations, we further note that we are able to reduce
hese to a single nonlinear ordinary differential equation by divid-
ng one equation by the other and seeking a solution to S¯ 2 ( ¯S 1 ) .
lthough this ﬁrst-order differential equation can be transformed
nto a linear second-order differential equation with solutions in-
olving modiﬁed Bessel functions, reintroducing t into this system
s nontrivial, and the solutions do not provide any insight into the
nderlying system behaviour. Therefore, we do not consider this
oute further. 
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